{"_id": "64e29cb671a8c404a9d437b6", "nctid": "NCT03718650", "title": "Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer: Establishing the Radiomic/Pathologic Foundation of Heterogeneity", "eligibilityCriteria": {"$and": [{"$and": [{"age": {"$gte": 18}}, {"histological diagnosis of pancreatic head ductal adenocarcinoma at least \u2265 1 cm from ampula": true}, {"able to undergo all 3 imaging modalities": true}, {"medical status considered appropriate for surgery and general anesthesia": true}, {"$or": [{"$and": [{"female participants or female partners of male participants undergoing optional PET-CT or CT pancreatic protocol scan": true}, {"$not": {"pregnant or nursing": true}}]}, {"$not": {"female participants of child-bearing potential": true}}]}, {"adequate kidney and liver function as assessed by laboratory studies completed within 28 days prior to pimonidazole administration": true}, {"capable of providing informed consent and demonstrate a willingness to comply with all study procedures and visits": true}, {"$not": {"contraindicated for MRI or gadolinium contrast agents": true}}, {"$not": {"known active cancer with a prognosis that would contraindicate a curative intent pancreatic resection": true}}, {"$not": {"depressed liver function as assessed with a screening liver function test": true}}, {"$not": {"presence of any other co-existing condition that might increase the risk to the patient": true}}]}, {"$not": {"women who are pregnant or breastfeeding": true}}, {"$not": {"participants with an iodine contrast allergy": true}}, {"$not": {"participants with a known active cancer with a prognosis that would contraindicate a curative intent pancreatic resection": true}}, {"$not": {"participants with depressed liver function": true}}, {"$not": {"presence of any other co-existing condition that might increase the risk to the patient": true}}]}, "healthyVolunteers": false, "sex": "ALL", "minimumAge": {"$gte": 18}, "stdAges": ["ADULT", "OLDER_ADULT"]}